Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs): an analysis of the FDA Adverse Event Reporting System (FAERS). | Expert Opin Drug Saf | 2024 | 37610085 | PubTator, text mining | PubMed |
| Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity. | Front Pharmacol | 2023 | 38259298 | PubTator, text mining | PubMed |
| Neutrophilic and eosinophilic dermatoses associated with hematological malignancy. | Front Med (Lausanne) | 2023 | 38249974 | PubTator, text mining | PubMed |
| Metabolomics in Animal Models of Bronchial Asthma and Its Translational Importance for Clinics. | Int J Mol Sci | 2023 | 38203630 | PubTator, text mining | PubMed |
| ANGPTL4 May Regulate the Crosstalk Between Intervertebral Disc Degeneration and Type 2 Diabetes Mellitus: A Combined Analysis of Bioinformatics and Rat Models. | J Inflamm Res | 2023 | 38161353 | PubTator, text mining | PubMed |
| Dupilumab suppresses relapsing chronic eosinophilic pneumonia with severe asthma. | Nagoya J Med Sci | 2023 | 38155613 | PubTator, text mining | PubMed |
| Eosinophilic Chronic Rhinosinusitis and Pathogenic Role of Protease. | Int J Mol Sci | 2023 | 38139201 | PubTator, text mining | PubMed |
| Oncostatin M's Involvement in the Pathogenesis of Chronic Rhinosinusitis: Focus on Type 1 and 2 Inflammation. | Biomedicines | 2023 | 38137445 | PubTator, text mining | PubMed |
| ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics. | Front Immunol | 2023 | 38090592 | PubTator, text mining | PubMed |
| Molecular mechanisms of pruritus in prurigo nodularis. | Front Immunol | 2023 | 38077377 | PubTator, text mining | PubMed |
| Targeting inflammation or remodeling in asthma? Is there a right way? | Front Med (Lausanne) | 2023 | 38076243 | PubTator, text mining | PubMed |
| Progress in diagnosis and treatment of difficult-to-treat asthma in children. | Ther Adv Respir Dis | 2023 | 38069568 | PubTator, text mining | PubMed |
| Epigenetics, hypersensibility and asthma: what do we know so far? | Clinics (Sao Paulo) | 2023 | 38043345 | PubTator, text mining | PubMed |
| Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration's adverse event reporting system (FAERS). | Front Pharmacol | 2023 | 38035014 | PubTator, text mining | PubMed |
| Initiation, response assessment, and switch of antibody therapies in patients with severe asthma - A survey among German specialists. | World Allergy Organ J | 2023 | 38033455 | PubTator, text mining | PubMed |
| Management of comorbidities in difficult and severe asthma. | Breathe (Sheff) | 2023 | 38020342 | PubTator, text mining | PubMed |
| Unanswered questions on the use of biologics in pediatric asthma. | World Allergy Organ J | 2023 | 38020283 | PubTator, text mining | PubMed |
| A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate-to-severe asthma. | Clin Transl Allergy | 2023 | 38006387 | PubTator, text mining | PubMed |
| Combination of Biological Therapy in Severe Asthma: Where We Are? | J Pers Med | 2023 | 38003909 | PubTator, text mining | PubMed |
| Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review. | J Clin Med | 2023 | 38002582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=13